Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drug conjugates
Biotech
German cancer antibody biotech eyes SPAC as route to Nasdaq
Market turmoil may have frozen the traditional IPO pipeline, but Veraxa is turning to the SPAC model to hop onto the Nasdaq.
James Waldron
Apr 23, 2025 6:09am
ADCs to cell therapy: How AZ aims to 'redefine' oncology
Apr 9, 2025 11:44am
Vincerx prepares to wind down as final merger attempt collapses
Apr 9, 2025 7:55am
BioAtla lays off 30% of staff, hunts for ADC partners
Mar 28, 2025 6:30am
MacroGenics pulls plug on ADC after seeing phase 2 survival data
Mar 21, 2025 7:15am
Zymeworks withholds one ADC from clinic in favor of another
Mar 6, 2025 10:25am
